|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 4214240 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22754752.8 |
| Date of filing the European patent application | 2022-07-27 | |
| (97) | Date of publication of the European application | 2023-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-09 |
| (46) | Date of publication of the claims translation | 2024-11-25 |
| (86) | Number | PCT/US2022/074214 |
| Date | 2022-07-27 |
| (87) | Number | WO 2023/010054 |
| Date | 2023-02-02 |
| (30) | Number | Date | Country code |
| 202163226118 P | 2021-07-27 | US |
| (72) |
MCCLUSKEY, Andrew, J. , US
SCHMIDT PAUSTIAN, Amanda, M. , US
SEAGAL, Jane , US
WILSBACHER, Julie, L. , US
|
| (73) |
AbbVie Inc. ,
1 N. Waukegan Road, North Chicago, IL 60064,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-CCR8 antikūnai |
| ANTI-CCR8 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-06-16 | 4 | 92.00 EUR |
| 2026-07-27 |